Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

SAL Unveils New Pharma and Perishable facilities in Riyadh in time for Covid vaccines distribution

Friday, November 27, 2020

Saudi Arabian Logistics Company SAL Saudi Arabias leading cargo ground handler and logistics provider is pleased to announce the unveiling of its new pharma and perishable facilities at the Cargo Village in Riyadh specializing in perishables and all...

Eppendorf SmartBlock™ for Cell Thawing: Reproducible and Reliable Process

Friday, November 27, 2020

Eppendorf offers now a further building block in supporting scientists with tailored solutions for the daily lab routine Controlled and reliable cell thawing is mandatory for further downstream experiments in every cell handling lab Although waterbat...

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

Friday, November 27, 2020

Rhythm Pharmaceuticals Inc a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity announced that the US Food Drug Administration FDA has approved IMCIVREE setmelanotide for...

Breakthrough in AML Treatment: GoldenBiotech Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia

Friday, November 27, 2020

Golden Biotechnology CorpGoldenBiotech TWO a leading Taiwanese biopharmaceutical company announces that its new drug Antroquinonol HOCENA outperforms the other listing drugs for the treatment of relapsed AML acute myeloid leukemia patients in its Pha...

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease

Friday, November 27, 2020

Protalix BioTherapeutics Inc a biopharmaceutical company focused on the development production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cellbased protein expression system and Chiesi Global...

Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis

Friday, November 27, 2020

Astellas Pharma Incand FibroGen Inc announced that Japans Ministry of Health Labour and Welfare MHLW approved EVRENZO roxadustat for the treatment of anemia of chronic kidney disease CKD in adult patients not on dialysis

PostEra and NeuroLucent collaborate on identifying small-molecule therapeutics for Alzheimer's disease

Thursday, November 26, 2020

PostEra a biotechnology company offering medicinal chemistry powered by machine learning today announced a collaboration with NeuroLucent a Chicagobased company focused on developing novel treatments for Alzheimers disease and other dementias The fai...

BioNTech and Fosun Pharma Announce the Start of Phase 2 Clinical Trial of Lead mRNA COVID-19 Vaccine BNT162b2 in China

Wednesday, November 25, 2020

BioNTech SE and Shanghai Fosun Pharmaceutical Group Co Ltd Fosun Pharma Stock Code SH HK jointly announced that their lead mRNA candidate COVID vaccine BNTb will conduct phase clinical trial in Taizhou and Lianshui Jiangsu Province China The phase...

RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA

Wednesday, November 25, 2020

RhoVac a clinical stage company today announced that the American FDA has granted Fast Track Designation to the companys drug candidate RV Fast Track Designation is granted to investigational drugs for expedited review by the FDA to facilitate develo...

Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of GM2 Gangliosidosis With PLX-300

Wednesday, November 25, 2020

Polaryx Therapeutics Inc a biotech company developing small molecule therapeutics for lysosomal storage disorders announced today that it has received from the US Food and Drug Administration FDA both Rare Pediatric Disease and Orphan Drug designatio...

ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment

Tuesday, November 24, 2020

ISD Immunotech ISD which is developing targeted therapies for severe autoimmune diseases announces it has entered into a strategic research collaboration with Biogen Inc Cambridge MA USA

Panaxia and Neuraxpharm Expand Strategic Collaboration to France with medical cannabis

Tuesday, November 24, 2020

Panaxia Global the controlling owner of Panaxia Labs Israel Ltd Panaxia Israel TASE PNAX Israels largest manufacturer of medical cannabis products and its partner Neuraxpharm Europes leading pharmaceutical company specialized in the central nervous s...

CytoDyn Announces Partnership with amfAR to Accelerate HIV Cure Research

Tuesday, November 24, 2020

CytoDyn Inc a latestage biotechnology company developing Vyrologix leronlimabPRO a CCR antagonist with the potential for multiple therapeutic indications announced today it signed an agreement with amfAR

AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation

Tuesday, November 24, 2020

ARCA biopharma Inc a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases announced that the US Food and Drug Administration FDA has designated as a Fast Track devel...

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person

Tuesday, November 24, 2020

Roche announced that the US Food and Drug Administration FDA has approved a supplemental New Drug Application sNDA for Xofluza baloxavir marboxil as a treatment to prevent influenza in people years of age and older following contact with someone wit...

Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysis

Tuesday, November 24, 2020

The National Medical Products Administration NMPA has approved a dosing label update in China for AstraZenecas Lokelma sodium zirconium cyclosilicate to include patients with hyperkalaemia on chronic haemodialysis The approval by the NMPA was based o...

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous

Tuesday, November 24, 2020

Bristol Myers Squibb announced that the European Commission EC has approved Opdivo nivolumab for the treatment of adults with unresectable advanced recurrent or metastatic esophageal squamous cell carcinoma ESCC after prior fluoropyrimidine and plati...

Glycostem initiates phase I/IIa (pivotal) trial to evaluate the safety and efficacy of oNKord® in patients with Acute Myeloid Leukemia (AML)

Monday, November 23, 2020

Glycostem Therapeutics BV a leading clinicalstage company focused on the development of therapeutic offtheshelf Natural Killer NK cells today announced the opening of a phase IIIa trial for its lead product oNKord for the treatment of AML patients

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

Monday, November 23, 2020

Positive highlevel results from an interim analysis of clinical trials of AZD in the UK and Brazil showed the vaccine was highly effective in preventing COVID the primary endpoint and no hospitalisations or severe cases of the disease were reported i...

Telstar consolidates a new high-standard process R+D laboratory service in China

Monday, November 23, 2020

Through an innovative sterilization freezedrying processes RD laboratory Telstar offers pharmaceutical companies located in China a qualified and complete consultancy service for the development qualification and validation of process cycles simplif...

Ascentage Pharma Receives Approvals for Two Phase Ib/II Clinical Studies of the Bcl-2 Inhibitor APG-2575 for the Treatment of Waldenström Macroglobulinemia and Multiple Myeloma in China

Monday, November 23, 2020

Ascentage Pharma HK a globally focused clinicalstage biotechnology company engaged in developing novel therapies for cancers chronic hepatitis B CHB and agerelated diseases today announced that the Center for Drug Evaluation CDE of China National Med...

Pierre Fabre and Y-Biologics are jointly researching new immunotherapies based on monoclonal antibodies

Monday, November 23, 2020

South Korean biotechnology company YBiologics and French pharmaceutical company Pierre Fabre are planning a strategic partnership to explore cancer immunotherapies The announcement took the form of a written letter of intent signed by both parties Th...

FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention

Monday, November 23, 2020

Today the US Food and Drug Administration expanded the approved indication for Xofluza baloxavir marboxil to include postexposure prevention of influenza flu for patients years of age and older after contact with an individual who has the flu

FDA Approves First Drug to Treat Rare Metabolic Disorder

Monday, November 23, 2020

Today the US Food and Drug Administration approved Oxlumo lumasiran as the first treatment for primary hyperoxaluria type PH a rare genetic disorder This approval is a cumulation of the work of experts and community members coordinated by the Oxalos...

Viatris Inc. Announces FDA Tentative Approval of a Pediatric Formulation of Dolutegravir (DTG) Under PEPFAR

Monday, November 23, 2020

Viatris Inca new kind of healthcare company today announced tentative approval from the US Food and Drug Administration FDA for a New Drug Application for pediatric dolutegravir tablets for oral suspension mg

European Commission approves MenQuadfi®, the latest innovation in meningococcal (MenACWY) vaccination for individuals 12 months of age and older

Monday, November 23, 2020

The European Commission EC has approved MenQuadfi for active immunization of individuals from the age of months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A C W and Y

GSK starts phase 3 study of RSV maternal candidate vaccine

Monday, November 23, 2020

GlaxoSmithKline plc announced that patient dosing has begun in a phase clinical programme investigating the safety and efficacy of its Respiratory Syncytial Virus RSV candidate vaccine for maternal immunisation GSKA following presentation of positiv...

Merck to Acquire OncoImmune

Monday, November 23, 2020

Merck known as MSD outside the United States and Canada and OncoImmune a privatelyheld clinicalstage biopharmaceutical company today announced that the companies have entered into a definitive agreement pursuant to which Merck through a subsidiary w...

Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine, for Use in Adults

Monday, November 23, 2020

Merck known as MSD outside the United States and Canada today announced the company has submitted applications to the US Food and Drug Administration FDA and European Medicines Agency EMA for licensure of V Mercks investigational valent pneumococcal...

Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors

Monday, November 23, 2020

Pfizer Inc today announced that the first participant has been dosed in the Phase BASIS study of marstacimab PF an antitissue factor pathway inhibitor antiTFPI being evaluated for the treatment of people with severe hemophilia A or B with or without...

Latest Issue
Get instant
access to our latest e-book
Thermo Fisher Scientific - Chromatography Solutions Eppendorf - Discover the Flow Syntegon - 6400 Machines Meco - 90 years